Quest Diagnostics Inc. (DGX)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Quest Diagnostics Inc. (DGX)
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Key Insights
Critical company metrics and information
Share Price
$157.92Market Cap
$17.63 BillionTotal Outstanding Shares
111.62 Million SharesTotal Employees
48,000Dividend
$0.75 Per Share QuarterlyIPO Date
December 17, 1996SIC Description
Services-medical LaboratoriesHomepage
https://www.questdiagnostics.com
Historical Stock Splits
If you bought 1 share of DGX before June 21, 2005, you'd have 2 shares today.
Execution Date | Split Amount |
---|---|
June 21, 2005 | 2-for-1 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $621.00 Million |
Net Cash Flow From Operating Activities, Continuing | $1.40 Billion |
Net Cash Flow From Investing Activities | $-2.16 Billion |
Net Cash Flow From Investing Activities, Continuing | $-2.16 Billion |
Net Cash Flow From Financing Activities, Continuing | $1.38 Billion |
Net Cash Flow | $621.00 Million |
Net Cash Flow From Operating Activities | $1.40 Billion |
Net Cash Flow From Financing Activities | $1.38 Billion |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Interest And Dividend Income, Operating | $24.00 Million |
Income/Loss From Continuing Operations Before Tax | $1.11 Billion |
Interest Income/Expense Operating, Net | $-176.00 Million |
Net Income/Loss | $890.00 Million |
Operating Income/Loss | $1.25 Billion |
Cost Of Revenue | $6.42 Billion |
Income/Loss From Equity Method Investments | $22.00 Million |
Other Operating Expenses | $159.00 Million |
Provision For Loan, Lease, And Other Losses | $0.00 |
Operating Expenses | $1.87 Billion |
Benefits Costs and Expenses | $8.43 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $4.00 Million |
Net Income/Loss Attributable To Parent | $841.00 Million |
Revenues | $9.54 Billion |
Selling, General, and Administrative Expenses | $1.71 Billion |
Income Tax Expense/Benefit, Deferred | $-31.00 Million |
Net Income/Loss Available To Common Stockholders, Basic | $841.00 Million |
Diluted Earnings Per Share | $7.44 |
Basic Average Shares | $334.00 Million |
Gross Profit | $3.12 Billion |
Costs And Expenses | $8.29 Billion |
Income Tax Expense/Benefit | $245.00 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $49.00 Million |
Nonoperating Income/Loss | $-139.00 Million |
Income/Loss Before Equity Method Investments | $1.11 Billion |
Diluted Average Shares | $336.00 Million |
Interest Income/Expense After Provision For Losses | $-176.00 Million |
Basic Earnings Per Share | $7.52 |
Income/Loss From Continuing Operations After Tax | $868.00 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Assets | $16.09 Billion |
Intangible Assets | $1.72 Billion |
Liabilities And Equity | $16.09 Billion |
Noncurrent Assets | $13.47 Billion |
Current Liabilities | $2.09 Billion |
Other Non-current Liabilities | $911.00 Million |
Other Current Assets | $2.44 Billion |
Noncurrent Liabilities | $7.16 Billion |
Redeemable Noncontrolling Interest | $80.00 Million |
Equity Attributable To Parent | $6.81 Billion |
Equity | $6.84 Billion |
Other Non-current Assets | $9.66 Billion |
Equity Attributable To Noncontrolling Interest | $32.00 Million |
Liabilities | $9.25 Billion |
Current Assets | $2.62 Billion |
Inventory | $184.00 Million |
Temporary Equity | $80.00 Million |
Fixed Assets | $2.09 Billion |
Long-term Debt | $6.25 Billion |
Historical Dividends
Current dividend: $0.75 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Nov 12, 2024 | Jan 29, 2025 | Jan 14, 2025 | $0.75 | Quarterly |
Aug 14, 2024 | Oct 21, 2024 | Oct 4, 2024 | $0.75 | Quarterly |
May 15, 2024 | Jul 22, 2024 | Jul 8, 2024 | $0.75 | Quarterly |
Feb 1, 2024 | Apr 22, 2024 | Apr 8, 2024 | $0.75 | Quarterly |
Nov 13, 2023 | Jan 31, 2024 | Jan 17, 2024 | $0.71 | Quarterly |
Aug 14, 2023 | Oct 23, 2023 | Oct 6, 2023 | $0.71 | Quarterly |
May 16, 2023 | Jul 25, 2023 | Jul 11, 2023 | $0.71 | Quarterly |
Feb 2, 2023 | Apr 24, 2023 | Apr 10, 2023 | $0.71 | Quarterly |
Nov 14, 2022 | Feb 1, 2023 | Jan 18, 2023 | $0.66 | Quarterly |
Aug 10, 2022 | Oct 19, 2022 | Oct 4, 2022 | $0.66 | Quarterly |
May 17, 2022 | Jul 20, 2022 | Jul 6, 2022 | $0.66 | Quarterly |
Feb 3, 2022 | Apr 20, 2022 | Apr 6, 2022 | $0.66 | Quarterly |
Nov 17, 2021 | Feb 2, 2022 | Jan 19, 2022 | $0.62 | Quarterly |
Aug 16, 2021 | Oct 20, 2021 | Oct 5, 2021 | $0.62 | Quarterly |
May 20, 2021 | Jul 21, 2021 | Jul 7, 2021 | $0.62 | Quarterly |
Feb 4, 2021 | Apr 21, 2021 | Apr 7, 2021 | $0.62 | Quarterly |
Nov 18, 2020 | Feb 3, 2021 | Jan 20, 2021 | $0.56 | Quarterly |
Aug 18, 2020 | Oct 21, 2020 | Oct 6, 2020 | $0.56 | Quarterly |
May 18, 2020 | Jul 22, 2020 | Jul 8, 2020 | $0.56 | Quarterly |
Jan 30, 2020 | Apr 21, 2020 | Apr 7, 2020 | $0.56 | Quarterly |
Nov 20, 2019 | Jan 29, 2020 | Jan 14, 2020 | $0.53 | Quarterly |
Aug 15, 2019 | Oct 21, 2019 | Oct 4, 2019 | $0.53 | Quarterly |
May 14, 2019 | Jul 22, 2019 | Jul 8, 2019 | $0.53 | Quarterly |
Mar 1, 2019 | Apr 22, 2019 | Apr 8, 2019 | $0.53 | Quarterly |
Nov 28, 2018 | Jan 30, 2019 | Jan 15, 2019 | $0.53 | Quarterly |
Aug 17, 2018 | Oct 22, 2018 | Oct 5, 2018 | $0.5 | Quarterly |
May 14, 2018 | Jul 23, 2018 | Jul 9, 2018 | $0.5 | Quarterly |
Feb 1, 2018 | Apr 18, 2018 | Apr 4, 2018 | $0.5 | Quarterly |
Nov 29, 2017 | Jan 24, 2018 | Jan 9, 2018 | $0.45 | Quarterly |
Aug 18, 2017 | Oct 18, 2017 | Oct 3, 2017 | $0.45 | Quarterly |
May 16, 2017 | Jul 24, 2017 | Jul 10, 2017 | $0.45 | Quarterly |
Feb 21, 2017 | Apr 19, 2017 | Apr 5, 2017 | $0.45 | Quarterly |
Aug 17, 2016 | Oct 19, 2016 | Oct 4, 2016 | $0.4 | Quarterly |
May 18, 2016 | Jul 20, 2016 | Jul 6, 2016 | $0.4 | Quarterly |
Dec 4, 2015 | Jan 27, 2016 | Jan 12, 2016 | $0.38 | Quarterly |
Aug 18, 2015 | Oct 21, 2015 | Oct 6, 2015 | $0.38 | Quarterly |
May 15, 2015 | Jul 22, 2015 | Jul 8, 2015 | $0.38 | Quarterly |
Jan 29, 2015 | Apr 22, 2015 | Apr 8, 2015 | $0.38 | Quarterly |
Dec 4, 2014 | Jan 28, 2015 | Jan 13, 2015 | $0.33 | Quarterly |
Aug 15, 2014 | Oct 22, 2014 | Oct 7, 2014 | $0.33 | Quarterly |
May 21, 2014 | Jul 23, 2014 | Jul 9, 2014 | $0.33 | Quarterly |
Jan 29, 2014 | Apr 23, 2014 | Apr 8, 2014 | $0.33 | Quarterly |
Dec 5, 2013 | Jan 22, 2014 | Jan 7, 2014 | $0.3 | Quarterly |
Aug 20, 2013 | Oct 16, 2013 | Oct 1, 2013 | $0.3 | Quarterly |
May 21, 2013 | Jul 17, 2013 | Jul 2, 2013 | $0.3 | Quarterly |
Feb 26, 2013 | Apr 16, 2013 | Apr 2, 2013 | $0.3 | Quarterly |
Nov 16, 2012 | Jan 28, 2013 | Jan 11, 2013 | $0.3 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Quest Diagnostics Inc. (DGX)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.